Skip to main content
U.S. flag

An official website of the United States government

Patent AT-E401406-T1: [Translated] CHICKEN ANAEMIA VIRUS MUTANT, VACCINES, AND USES BASED ON VIRUS PROTEIN VP3, OR VIRUS SEQUENCES ENCODING THEREOF

Published by National Center for Biotechnology Information (NCBI) | U.S. Department of Health & Human Services | Catalog Last Checked: July 31, 2026 at 09:32 PM | Dataset Last Updated: September 06, 2025
Novel proteins of the Chicken Anemia Virus are described and compositions for preventing or treating infections with that virus (CAV), in particular vaccines less pathogenic than the CAV itself, but yet leading to neutralizing antibodies in the immunized animal. Besides, there are described compositions containing antibodies against parts of the CAV for the control of infections with CAV and anti-idiotype antibodies which possess an immunogenicity corresponding to the antigen. The invention also provides antibodies for the detection of CAV infections and test kits for the detection of CAV. Recombinant DNA molecules derived from CAV coding for an immunogenic part of a CAV protein and host cells transfected with such DNA molecules and vaccines based on these host cells are made possible by this invention. Also, living virus vaccines in which a piece of DNA coding for an immunogenic part of a CAV protein is brought into a virus infectious to the desired host are a subject of the invention. Besides, the invention relates to uses of proteins of CAV in the induction of apoptosis, in particular, the proteins can be used in induction of apoptosis in tumor cells. The invention further provides the induction of cell death by means of gene therapy.

Resources

1 resource available

Find Related Datasets

Search by Tags

Click any tag below to search for similar datasets

data.gov

An official website of the GSA's Technology Transformation Services

Looking for U.S. government information and services?
Visit USA.gov